IND Swift Limited Sulfasalazine Export Data — India (DGFT 2022–2026)

Name: IND Swift Limited Sulfasalazine Export Records India — #1 Exporter, 14 Shipments, $700.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sulfasalazine

India Pharmaceutical Trade Intelligence

$3.2M93 Suppliers49 CountriesHS 30049099

ExportsIndia → NETHERLANDS34.3%India → SRI LANKA25.2%

ImportsUNITED STATES → India$9.2K BULGARIA → India$1.3K

#1 Supplier: IND SWIFT

IND Swift Limited — Sulfasalazine Exporter #1 | $850.0K Trade Value | TransData Nexus | TransData Nexus

IND Swift Limited — Sulfasalazine Exporter Profile

Indian Pharmaceutical Exporter · #1 for Sulfasalazine · $850.0K export value · DGFT Verified

IND Swift Limited is the #1 Indian exporter of Sulfasalazine with $850.0K in export value and 14 verified shipments. IND Swift Limited holds a 21.8% market share in Sulfasalazine exports across 1 countries. The company exports 13 pharmaceutical products worth $36.7M across 9 therapeutic categories.

IND Swift Limited — Sulfasalazine Export Profile: Buyers & Destinations

IND Swift Limited Sulfasalazine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Sulfasalazine?

Country	Value	Shipments	Share
NETHERLANDS	$850.0K	17	29.5%
SRI LANKA	$809.7K	28	28.1%
UNITED ARAB EMIRATES	$359.1K	12	12.5%
CHILE	$150.0K	3

Who Are the Top Buyers of Sulfasalazine from India?

Buyer	Country	Value	Orders
M/S.PHARMA ASSOCIATES	SRI LANKA	$155.1K	7
MYLAN B V	NETHERLANDS	$150.0K	3
EMAR PHARMA (PVT) LTD	SRI LANKA	$133.6K	3
MYLAN IRELAND LTD	NETHERLANDS	$115.1K	3
M/S. MYLAN B.V C/O ALLOGA	NETHERLANDS	$100.0K	2
MYLAN B V C O ALLOGA	NETHERLANDS	$100.0K	2
MYLAN B.V.C/O ALLOGA	NETHERLANDS	$100.0K	2
MYLAN B.V.	NETHERLANDS	$100.0K	2
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$96.6K	2
JV DOMINIK LLC 25 BRIKETA ST	BELARUS	$82.3K	2

India's Sulfasalazine is purchased by 137 buyers worldwide. The top buyer is M/S.PHARMA ASSOCIATES (SRI LANKA), followed by MYLAN B V and EMAR PHARMA (PVT) LTD.

How Does IND Swift Limited Compare to Nearest Sulfasalazine Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	IND SWIFT LIMITED ★	$700.0K	14	1	$50.0K
2	WALLACE PHARMACEUTICALS PRIVATE LIMITED	$534.9K	12	3	$44.6K
3	INDOCO REMEDIES LIMITED	$259.0K	11	1	$23.5K

IND Swift Limited ranks #1 among 93 Indian Sulfasalazine exporters. Average shipment value of $50.0K compared to the market average of $26.4K. The closest competitors by value are WALLACE PHARMACEUTICALS PRIVATE LIMITED and INDOCO REMEDIES LIMITED.

Which Indian Ports Ship Sulfasalazine Exports?

Port	Shipments	% Share
SAHAR AIR	114	24.2%
SAHAR AIR CARGO ACC (INBOM4)	76	16.1%
DELHI AIR CARGO ACC (INDEL4)	68	14.4%
DELHI AIR	48	10.2%
JNPT/ NHAVA SHEVA SEA	17	3.6%
Bombay Air	15	3.2%
NHAVA SHEVA SEA (INNSA1)	14	3.0%
AHEMDABAD AIR	12	2.5%

Geopolitical & Trade Policy Impact on IND Swift Limited's Sulfasalazine Exports

Ind-Swift Laboratories' export operations have been influenced by recent geopolitical developments. The Israel-Iran conflict has heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the company's logistics and cost structures. (livemint.com)

Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded in January 2026, is poised to benefit Indian pharmaceutical exporters. The agreement eliminates tariffs on most European pharmaceutical imports, enhancing the competitiveness of Indian products in the EU market. This development presents an opportunity for Ind-Swift Laboratories to expand its footprint in Europe. (en.wikipedia.org)

In the United States, the reshoring of pharmaceutical manufacturing and potential imposition of tariffs on imports pose challenges for Indian exporters. While there are currently no import duties on Indian pharmaceutical products entering the US, the introduction of tariffs could affect the profitability of low-margin generic drugs, potentially leading to market exits. (cfo.economictimes.indiatimes.com)

IND Swift Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Indian pharmaceutical exporters. Ind-Swift Laboratories has demonstrated a commitment to quality by adhering to Good Manufacturing Practices (GMP) as stipulated by the US FDA, WHO, and EU authorities. The company's manufacturing facilities in Punjab and Jammu have been inspected and approved by these regulatory bodies, facilitating access to regulated markets.

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous investment in quality systems and supply chain transparency. Ind-Swift Laboratories' focus on high-margin formulations underscores the importance of maintaining stringent quality standards to meet global regulatory requirements and sustain market access.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sulfasalazine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: IND Swift Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 49+ countries, 137+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sulfasalazine

Sulfasalazine

IND Swift Limited — Sulfasalazine Exporter Profile

IND Swift Limited — Sulfasalazine Export Profile: Buyers & Destinations

Where Does India Export Sulfasalazine?

Who Are the Top Buyers of Sulfasalazine from India?

What Is India's Total Sulfasalazine Export Value and How Much Does IND Swift Limited Contribute?

What Is the Average Shipment Value for IND Swift Limited's Sulfasalazine Exports?

How Does IND Swift Limited Compare to Other Indian Sulfasalazine Exporters?

How Does IND Swift Limited Compare to Nearest Sulfasalazine Exporters?

Which Indian Ports Ship Sulfasalazine Exports?

What Other Gastrointestinal Products Does IND Swift Limited Export?

Geopolitical & Trade Policy Impact on IND Swift Limited's Sulfasalazine Exports

IND Swift Limited — Regulatory Compliance & Quality Standards

About IND Swift Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sulfasalazine Export Data from IND Swift Limited

Sulfasalazine Stats

Company Overview

Top Products by IND Swift Limited

Related Analysis

Need Detailed Export Data?

Data Source